NIPS BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche The business will complement BioReference's specialty health division GenPath, which offers a noninvasive prenatal screening test. Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium During a conference call, company executives also discussed results from the SMART NIPT trial and their outlook for Natera's three businesses. Natera Revenues Grow 35 Percent in Q4 The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million. Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium In a study involving 1,300 blood samples from pregnant women, Myriad researchers demonstrated that their method could increase the fetal fraction for almost all. Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium The company plans to show new data for its Signatera oncology test at three upcoming conferences this year, including in breast cancer and bladder cancer. Nov 5, 2020 Natera Q3 Revenues Up 26 Percent on Increased Testing Volumes Oct 26, 2020 Yourgene H1 Revenues Up 5 Percent Oct 8, 2020 Centene Expands Coverage of Natera NIPT to All Pregnant Women Sep 17, 2020 SVB Leerink Initiates Coverage of Natera With Outperform Rating Sep 11, 2020 Natera Prices $250M Public Stock Offering Aug 17, 2020 ACOG Guidelines Recommend NIPT for All Pregnancies Regardless of Risk Jul 7, 2020 Progenity Asks Court to Declare Non-Infringement of Natera Patents Jun 17, 2020 Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents May 12, 2020 Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal May 6, 2020 Natera Q1 Revenues Grow 41 Percent Apr 20, 2020 Yourgene Health Fiscal 2020 Revenues Up 86 Percent Apr 14, 2020 Natera Prices $250M Senior Notes Offering Apr 13, 2020 Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering Feb 5, 2020 Medical Organizations Form Reproductive Genetics Technology Consortium Dec 17, 2019 PerkinElmer Aims to Attract Vanadis NIPT Customers Through Service, Validation Studies Premium Nov 8, 2019 Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains Premium Nov 6, 2019 Natera Reports 19 Percent Increase in Q3 Revenues Nov 5, 2019 FindGene Noninvasive Prenatal Screening Kit Gets Approval from Chinese Regulators Oct 23, 2019 National Council on Disability Recommends More Regulation of NIPT Oct 10, 2019 LabCorp Shows Improved Performance for NIPT in Multifetal Pregnancies but Outcome Data Sparse Premium Load More Breaking News UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.